Delivery Order SPE2DB22D2214-SPE2DB24FS6TS

Award Date 9/19/24
Potential Completion Date 9/20/24
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for $23,368.75. The contract is for the delivery of BREYNA 160-4.5 MCG INHALER 10.3GM, a pharmaceutical product, with a completion date of December 24, 2024. The order is a Firm Fixed Price contract without any set-aside requirements. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,980.39 firm fixed-price contract is for the delivery of BREYNA 160-4.5 MCG INHALER 10.3GM, a medical supply product. The contract has an ultimate completion date of May 9, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,270.34, is for the delivery of BREYNA 160-4.5 MCG INHALER 10.3GM medical supplies. The contract is a firm fixed-price delivery order with a completion date of March 19, 2025. The award is not associated with a set-aside designation. Amerisourcebergen Drug Corp holds...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the BREYNA 80-4.5 MCG INHALER 10.3GM medication. The delivery order has a firm fixed-price, non-set-aside contract type with a ceiling value of $1,635.99 and a period of performance extending through June 11, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,921.57, is for the delivery of BREYNA 160-4.5 MCG INHALER 10.3GM medical supplies. The contract has an ultimate completion date of May 13, 2024 and is a firm fixed-price delivery order. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,289.08, is for the delivery of BREYNA 160-4.5 MCG INHALER 10.3GM medical supplies. The contract has an ultimate completion date of January 21, 2025 and is a firm fixed-price agreement. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,129.00 firm fixed-price contract is for the delivery of BREYNA 160-4.5 MCG INHALER 10.3GM medical supplies. The award is not subject to any set-aside requirements. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,280.97, is for the delivery of BREYNA 160-4.5 MCG INHALER 10.3GM medical supplies. It is a Firm Fixed Price contract with a period of performance through March 26, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of a pharmaceutical product, specifically the BREYNA 160-4.5 MCG INHALER 10.3GM, at a firm fixed price of $17,991.07. The contract is set to expire on September 12, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,694.03, is for the procurement of BREYNA 160-4.5 MCG INHALER 10.3GM, a medical product. The contract has an ultimate completion date of January 16, 2025 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger...
  • SPE2DB22D2214
    Indefinite Delivery Contract
  • SPE2DB22D2214-SPE2DB24FS6TS
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the BREYNA 160-4.5 MCG INHALER 10.3GM medication. The contract has a firm fixed price of $2,428.87 and an ultimate completion date of September 20, 2024. Amerisourcebergen holds a broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which serves as the primary vehicle for providing a wide range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. This specific delivery order is not designated as a set-aside contract.

Generated 12/19/24, 9:38 AM